Wolfe, Caitlin E; Wood, David M; Dines, Alison; Whatley, Benjamin P; Yates, Christopher; Heyerdahl, Fridtjof; Hovda, Knut Erik; Giraudon, Isabelle; Dargan, Paul I (2019). Seizures as a complication of recreational drug use: Analysis of the Euro-DEN Plus data-set. NeuroToxicology, 73, pp. 183-187. Elsevier 10.1016/j.neuro.2019.04.003
Text
Wolfe, Neurotoxycology 2019.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (409kB) |
Seizures are a recognized and potentially serious complication of recreational drug use. This study examined a large international data set of presentations to Emergency Departments with acute recreational drug toxicity, the European Drug Emergencies Plus (Euro-DEN Plus) Network, to compare presentations with and without seizures and estimate incidence and associated drugs. Amongst 23,947 presentations between January 2014 and December 2017, there were 1013 (4.2%) with reported seizures. Clinical and demographic features were similar between individuals who had a seizure and those who did not, although rates of coma, cardiac arrest, intubation, intensive care admission, and death were significantly higher in those with seizures. There was a significant association between specific drugs and a higher seizure incidence, including fentanyl (odds ratio 2.63, 95% confidence interval 1.20-5.80), and synthetic cannabinoids (OR 2.90, 95% CI 2.19-3.84). Other drugs were associated with a lower seizure incidence, including heroin (OR 0.46, 95% CI 0.35-0.61), clonazepam (OR 0.22, 95% CI 0.06-0.91), and cannabis (OR 0.65, 95% CI 0.50-0.86). This substantiates observations that the synthetic cannabinoids as a group of novel psychoactive substances are clinically different in consequence of intoxication than cannabis, and that individuals who suffer a seizure in the context of recreational drug intoxication are likely to have worse outcomes overall. Utilising this information of what substances have a greater risk of seizures, could provide tailored harm reduction and education strategies to users to reduce the risk of seizures and their associated complications.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1872-9711 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Tobias Tritschler |
Date Deposited: |
28 Jan 2020 12:21 |
Last Modified: |
07 Sep 2021 17:17 |
Publisher DOI: |
10.1016/j.neuro.2019.04.003 |
PubMed ID: |
30974132 |
Additional Information: |
Evangelia Liakoni is a member of the Euro-DEN Plus Research Group. |
Uncontrolled Keywords: |
Acute toxicity New psychoactive substances Recreational drug Seizure Synthetic cannabinoid |
BORIS DOI: |
10.7892/boris.138339 |
URI: |
https://boris.unibe.ch/id/eprint/138339 |